Aberrant mitochondria in two human colon carcinoma cell lines

Area of Science:

• Cell Biology
• Cancer Research
• Mitochondrial Biology

Background:

• Differentiated human colon carcinoma cell lines (CCL237, FET) display distinct mitochondrial morphology.
• Comparison with normal (CV-1) and other carcinoma (MIP101) cell lines highlights unique mitochondrial features.

Purpose of the Study:

• Investigate mitochondrial respiratory activity and membrane potential in colon carcinoma cells.
• Determine if impaired oxidative metabolism in cancer cells can be therapeutically exploited.

Main Methods:

• Electron microscopy to visualize mitochondrial structure.
• Polarographic measurement of mitochondrial respiratory activity and respiratory control ratios.
• Tetraphenylphosphonium uptake assay to assess mitochondrial membrane potential.
• Treatment with 2-deoxyglucose to evaluate glycolytic inhibition effects.

Main Results:

• CCL237 and FET cells show enlarged mitochondria with reduced cristae and loosely coupled oxidative phosphorylation (respiratory control ratio ~3 vs >10).
• Mitochondrial membrane potential is lower in CCL237 and FET cells, with impaired hyperpolarization response.
• FET cell mitochondria exhibit reduced ADP-stimulated and uncoupled respiratory rates, indicating impaired oxidative phosphorylation capacity.
• 2-deoxyglucose selectively reduced FET cell viability, suggesting sensitivity to glycolysis inhibition.

Conclusions:

• Differentiated colon carcinoma cells (CCL237, FET) possess defective mitochondria with impaired oxidative phosphorylation.
• Mitochondrial membrane potential is compromised in these cancer cells.
• Exploiting the metabolic vulnerability of impaired oxidative metabolism presents a potential avenue for colon cancer chemotherapy.